Donoghue Forlines’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-18,498
Closed -$624K 274
2022
Q2
$624K Sell
18,498
-2,811
-13% -$98.5K 0.16% 167
2022
Q1
$744K Buy
21,309
+5,762
+37% +$197K 0.16% 207
2021
Q4
$473K Buy
+15,547
New +$506K 0.08% 238

Other funds holding OGN

Donoghue Forlines's OGN Position: Q3 2022 in Review

Donoghue Forlines sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 18,498 shares — an estimated $624K sold.

Donoghue Forlines first reported a position in OGN in Q4 2021 and held it in 3 quarters. The position peaked at $744K in Q1 2022. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Donoghue Forlines reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Donoghue Forlines sold 18,498 Organon & Co shares in Q3 2022, an estimated $624K.
  • Donoghue Forlines first reported a position in Organon & Co in Q4 2021 and held it in 3 quarters.
  • Donoghue Forlines's Organon & Co position peaked at $744K in Q1 2022.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Donoghue Forlines's 13F filing for Q3 2022, filed 7 Nov 2022.